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The end-systolic pressure-volume relation has been pos-
tulated as a load-independent measure of cardiac con-
tractility, but has been difficult to measure because of
technical problems associated with the serial measure-
ment of intracardiac volume over a physiologic range of
ventricular loading conditions. Utilizinga multielectrode
impedance catheter to assess continuous, on-line left ven-
tricular relative volume during transient inferior vena
cava occlusion, a method is described for determining
the end-systolic pressure-volume relation and for as-
sessing changes in this relation secondary to inotropic
modulation. In particular, using this method, the rela-
tive inotropic properties were determined of four drugs:
dobutamine, milrinone, epinephrine and an experimen-
tal cardiotonic agent (Ro 13-6438, Posicor).
Left ventricular micromanometer pressure and
impedance catheter volume were measured continuously
in 10 open chest, anesthetized dogs and 14 pigs. Arterial
pressure was altered over a range of 20 to 60 mm Hg
by brief inferior vena cava constriction. A linear end-
systolic pressure-volume relation was observed in pres-
sure-volume diagrams constructed from on-line pressure
The end-systolic pressure-volume relation has been pro-
posed as a load-independent indicator of cardiac contractility
which is sensitive to inotropic modulation (1-4). Deter-
mination of end-systolic contractile indexes in the intact
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and impedance catheter recordings. Administration of
dobutamine, milrinone and epinephrine resulted in a
leftward shift and an increase in the slope of the end-
systolicpressure-volume relation as compared with base-
line; Posicor did not alter the slope over a range of doses,
despite an increase in the cardiac output secondary to
arterial vasodilation. Volume changes as measured by
the impedance method closely paralleled simultaneous
changes in the ultrasonic crystal-determined segment
length, and the impedance end-systolic pressure-volume
relation slope was reproducible with repeated load-
altering manuevers.
It is concluded that the end-systolic pressure-
impedance volume relation can be determined on a beat
to beat basis during acute decreases in ventricular pre-
load induced by transient inferior vena cava occlusion.
This method of determining relative changes in the end-
systolic pressure-volume relation may be useful in the
assessment of relative inotropic effects of experimental
cardiotonic drugs.
(J Am Coil CardioI1986;8:1152-60)
organism, however, has been difficult. This is primarily due
to technical limitations of current techniques to measure
ventricular volumes over a range of physiologic loading
conditions, while still maintaining constant contractility. As
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a result, there has been interest both in assessment of new
methods of chamber volume measurement and in new tech-
niques to alter ventricular loading conditions in an attempt
to facilitate end-systolic pressure-volume analysis.
One area of potential utility of end-systolic contractile
indexes is the assessment of the mechanism of action of
new cardiotonic drugs. An experimental cardiotonic agent
may improve ventricular performance by acting as an ino-
trope or by favorably changing ventricular loading condi-
tions, or by having both effects. Routinely used ejection
phase contractile indexes often are unable to distinguish
between these two mechanisms because these measurements
are primarily load dependent. End-systolic contractile in-
dexes, however, are insensitive to loading conditions and,
at least theoretically, are able to distinguish between an
inotrope and a vasodilator.
The continuous on-line recording of intraventricular elec-
trical impedance has been documented previously as an
accurate method for instantaneously monitoring left ven-
tricular relative chamber volumes (5-10). Preliminary stud-
ies have also shown the utility of the impedance method for
measuring the left ventricular end-systolic pressure-volume
relation over a range of ventricular loading conditions (9,10),
but there has been no report on the use of this technique to
assess changes in the end-systolic pressure-volume relation
secondary to inotropic modulation. Utilizing a multielec-
trode impedance catheter with a 1.3 kHz measuring current
of 4 /-LA in combination with transient inferior cava occlu-
sion, we describe a method for determining a baseline left
ventricular end-systolic pressure-volume relation in open
chest anesthetized animals and for assessing relative ino-
tropic changes with the administration of cardiotonic drugs.
This technique was successfully applied in both dogs and
pigs.
Methods
Study design. Left ventricular high fidelity microma-
nometer pressure and impedance volume signals were re-
corded continuously over a range of ventricular loading
conditions induced by inferior vena cava occlusion in a total
of 24 anesthetized open chest animals, including 10 dogs
initially and 14 pigs subsequently. (During the course of
the study, dogs became extremely difficult to obtain and our
laboratory has switched, almost entirely, to the use of farm-
bred pigs.) Left ventricular pressure tracings and impedance
volume signals were subsequently digitized to produce pres-
sure-volume diagrams and to determine a baseline end-sys-
tolic pressure-volume relation. Changes in this relation were
assessed after intravenous infusion of four cardiotonic drugs,
including dobutamine, milrinone, epinephrine and Ro 13-
6438 (Posicor) (11), Changes in the end-systolic pressure-
volume relation were confirmed in all animals by deter-
mining simultaneous changes in the end-systolic pressure-
dimension relation using ultrasonic crystals.
This study was performed in two parts: in part 1, the
end-systolic pressure-volume relation was assessed during
the steady state infusion of dobutamine and before and after
the administration of an intravenous bolus of milrinone in
dogs. In part 2, a more complete hemodynamic study was
carried out in pigs and the end-systolic pressure-volume
relation was assessed during administration of graded in-
travenous doses of Posicor and after the steady state infusion
of intravenous epinephrine.
Surgical preparation. Part 1. In the first portion of the
study, 10 mongrel or retired racing greyhound dogs were
premedicated with ketamine intravenously (10 mg/ml) and
anesthesia was induced with chloralose (100 mg/kg). Res-
piration was supported mechanically using room air after
placement of an oral endotracheal tube. Periodic injections
of 100 mg chloralose were given intravenously as required
to maintain adequate anesthesia. A left lateral thoracotomy
was performed, and the pericardium was incised to support
the heart. The inferior vena cava was isolated and a length
of umbilical tape was passed around it and passed through
a short length of tubing to create a snare, thereby allowing
the rapid and reversible partial interruption of venous return.
Left ventricular pressure was monitored with a microma-
nometer-tipped catheter (Millar Instruments) passed retro-
grade from the carotid artery. A 7F thermodilution Swan-
Ganz catheter was inserted into the internal jugular vein and
advanced to the pulmonary artery to monitor thermodilution
cardiac output. The impedance catheter (Cardiac Pace-
makers Inc.) was also placed in the left ventricle after pass-
ing retrograde from the carotid artery, and driving and sen-
sing electrodes were selected to span the left ventricular
cavity (see later). Catheter position was not changed after
initial placement.
Part 2. In the second portion of the study, 14 farm-
raised young pigs (31 to 48 kg) were premedicated with
ketamine before induction of anesthesia with thiamylal (10
mg/kg) intravenously. Bolus injections of chloralose (l00
mg/kg) were given as necessary to maintain anesthesia.
Respirations were maintained with mechanical ventilation
and supplemental oxygen at 4 liters/min by way of an en-
dotracheal tube placed through a tracheostomy. Adequacy
of ventilation was ascertained by periodic determinations of
arterial and pulmonary artery blood oxygenation; arterial
oxygen saturation was maintained above 95% in all exper-
iments. A median sternotomy and pericardial incision were
performed to expose and support the heart, and the inferior
vena cava was isolated and a snare was placed. The animals
were anticoagulated with heparin, 4,000 U intravenous bolus,
followed by 1,000 U/h bolus injections. A left ventricular
rnicromanometer-tipped catheter and a thermodilution Swan-
Ganz catheter were placed in the left ventricle and pul-
monary artery, respectively, as described in part 1 of the
study. In part 2 of the study the rate of rise of left ventricular
pressure (dP/dt), as derived electronically from the high
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and
Resistance at end-diastole and end-systole can now be de-
fined as
where ed = end-diastole and es = end-systole. By com-
bining these two equations and subtracting we get
Ved - Yes = P U (Res - Red)/(Red)(Res). (5)
Thus , for a given cylinder of blood between any two sensing
electrodes, the change in volume that occurs with ventricular
contraction can bedetermined from the difference in imped-
ance between end-systole and end-diastole .
No attempt was made to calibrate impedance volume
signals to determine absolute ventricular volumes . Instead,
the initial end-diastole impedance volume was designated
as VI and the initial end-systolic volume was determined
by measuring the forward stroke volume (thermodilution
cardiac output/heart rate) and subtracting it from VI. Volume
changes during inferior vena cava occlusion and drug admin-
istration were subsequently measured relative to the initial
end-diastolic and end-systolic volumes.
Ultrasonic crystal dimension. In all animals, ultrasonic
crystals were implanted in the left ventricular subendocar-
dium approximately I em apart in an equatorial plane in the
midventricle. These were activated by a commercially avail-
able sonomicrometer (Triton Technologies Inc.). The crystal
separation was electronically calibrated and the crystal po-
sition ing confirmed at the end of each experiment at nee-
roscopic examination.
Hemodynamic, impedance volume and dimension
data. Following placement of the right heart thermodilution
catheter and the left ventricular micromanometer and imped-
ance catheters and ultrasonic crystals , baseline recordings
of heart rate , hemodynamic data, impedance volume and
ultrasonic crystal dimension were made . Next , inferior vena
.cava occlusion , with respirations suspended, was applied in
all animals to interrupt venous return with a subsequent fall
in left ventricular systolic pressure. Continuous on-line re-
cording s of left ventricular pressure, volume and dimen sion
were made on a beat by beat basis over a 20 to 60 mm Hg
fall in systolic pressure. Pressure declined smoothly over
10 to 20 beats until the constriction was released at a peak
systolic pressure of approximately 55 mm Hg. Inferior vena
cava occlusion was then discontinued with a subsequent
return of heart rate, pressure, volume and dimension to
baseline . For all animals hemodynamic data recorded at
baseline included mean and phasic pulmonary artery , pul-
monary wedge and aortic pressures. Thermodilution cardiac
output was determined in triplicate with 10 ml bolus injec-
tions of ice-cold saline solution with an Edwards model
cardiac output computer. Heart rate was determined from
recording s of the electrocardiogram over at least a 10 second
interval.
In part 2 of the study (Posicor and epinephrine) , mean
right atrial pressure was also recorded and the following
indexes were derived : stroke volume (ml) was calculated
from the formula stroke volume = cardiac output/heart rate;
systemic vascular resistance (dynes-s-cm- 5) from systemic
vascular resistance = (mean aortic pressure - mean right
atrial pressure) (80)/cardiac output ; and pulmonary vascular
resistance (dynes-s-cm- 5) from pulmonary vascular resist-
ance = (mean pulmonary artery pressure - mean pul-
(4)
(I)
(3)
(2)R = pUN
R = p LlA.
where R = resistance, P = resistivity of blood, L = dis-
tance between sensing electrodes and A = cross-sectional
area . For a cylindrical volume where volume (V) is equal
to cross-sectional area times length (A x L), equation 2
may be substituted for resistance.
fidelity pressure recording , was acquired as well. The
impedance catheter used in this part of the study was iden-
tical to that used in part 1. In these animals , the impedance
catheter was inserted into the left ventricular cavity through
an apical stab incision and the tip of the catheter was passed
out the aortic valve, and remained in that position for the
duration of the study. All pressure and impedance data were
recorded on a Honeywell Electronics for Medicine model
VR-16 or a Gould ES 1000 recorder.
Impedance measurements. The impedance catheter
system used in this study has been described previously (9).
Briefly, it consists of a 9F catheter that tapers to an 8F end-
hole distal shaft with 12 platinum ring electrodes spaced at
I em intervals along the distal end of the catheter. Once the
catheter was positioned in the left ventricular cavity, a 1.3
kHz alternating driving current of 4 p,A was applied to the
electrode pair spanning the ventricular cavity. Impedance
volume signals were recorded subsequently from a pair of
sensing electrodes located between the driving electrodes
within the left ventricular cavity. Impedance measurements
throughout the experiment utilized the same driving and
sensing electrode pairs as at baseline.
The theoretical basis of volume determination from
impedance has been described previously (5-10). As a first
approximation, the volume of blood that is measured be-
tween any two sensing electrodes can be considered to be
a cylinder with boundaries defined by the endothelial sur-
faces of the cardiac walls and by the equipotential surfaces
through the electrodes. The change in impedance sensed
during atrial contraction in anyone of these cylinders is
caused by a change in resistance between the two sensing
electrodes as a result of a change in the cross-sectional area
of the cylinder. The relation between resistance and cross-
sectional area is given by
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Figure I. Continuous on-line recordings of left ventricular pres-
sure, impedance volume and ultrasonic crystal dimension during
inferior vena cava(lVC) occlusion. Arrows mark onset and release
of occlusion. Impedance volume and crystal dimension closely
parallel each other. Impedance volume is expressed relative to
initial end-diastolic volume (VI) '
monary wedge pressure) (80)/cardiac output. The maximal
rate of rise in left ventricular pressure (peak positive dP/dt)
(mm Hg/s) was determined from the electronically cali-
brated signal.
Administration of cardiotonic drugs. After the re-
cording of data at baseline and during inferior vena cava
occlusion, and a subsequent return of pressure, volume and
dimension to baseline with the release of inferior vena cava
occlusion, cardiotonic drugs were administered to all ani-
mals.
Part 1. In five dogs a steady state infusion of dobutamine
at 10 J.Lg/kg per min was begun. In five additional dogs a
bolus injection of milrinone of 10 J.Lg/kg was given. Five
minutes after drug administration, after the establishment
of a new steady state, heart rate, thermodilution cardiac
output, left ventricular pressure, impedance volume and
ultrasonic crystal dimension were again recorded at baseline
and during inferior vena cava occlusion.
Part 2 . In 14 pigs progressive doses of Posicor were
administered as described later. The Posicor was stored at
- 200e as a lyophilized powder, and reconstituted by dis-
Figure 2. Pressure-volume (left) and
pressure-dimension (right) diagrams
obtained from digitization of data in
Figure I . End-systolic pressure-vol-
ume and pressure-dimension points both
show a progressive leftward and
downward displacement during infe-
riorvena cava occlusion. VI = initial
end-diastolic impedance volume; Vr
10 to VI-40 = VI - forward stroke
volume (end-systolic impedance vol-
ume) .
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Figure 3. Left ventricular pressure-vol-
ume diagrams obtainedfrom two sequen-
tial inferior vena cava occlusions in the
same animal. The end-systolic slope is
1.6 mm Hg/ml in both examples. Again,
left ventricular volumeis represented rel-
ative to initial end-diastolic volume (VI)'
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solving in a solution of 50% distilled water, 25% polypro-
pylene glycol and 25% ethanol at a concentration of I mg/ml.
This solution was made fresh at room temperature with each
experiment. Posicor was administered as an intravenous
bolus over 30 seconds at a dose of 30 jLg/kg. At 5 and 25
minutes after the administration of the first dose, complete
hemodynamic data acquisition and a repeat recording of left
ventricular pressure and impedance volume during inferior
vena cava constriction were performed. At 30 minutes after
the administration of the first dose, a second dose of 100
jLg/kg was given and the data were recorded similarly. This
dose was followed at 30 minutes by the final bolus admin-
istration of 300 jLg/kg, and the data were again recorded at
5 and 25 minutes after administration.
In seven pigs, this protocol was followed by the admin-
istration of epinephrine at a steady state rate of 2 jLg/min.
Hemodynamic information and left ventricular pressure and
impedance volume during inferior vena cava constriction
were recorded after the animal had been in a steady state
for at least 10 minutes after the start of the infusion.
Data analysis. Micromanometer pressure and imped-
ance catheter volume were digitized off-line from the re-
corded data using a Tektronix 4052 computer interfaced with
a Tektronix 4956 graphics tablet, and pressure-volume loops
were constructed from the digitized data. Ectopic ventricular
beats, postextrasystolic beats and beats with a peak systolic
pressure of less than 60 mm Hg were excluded from anal-
ysis. The end-systolic pressure-volume point for each car-
diac cycle was defined as the maximal ratio of pressure to
impedance volume. Emax was defined as the slope of the
end-systolic pressure-volume relation (I) and was deter-
mined by fitting a line to these points by linear regression.
Only pressure-volume loops in which there had been less
than a 5% change in heart rate during inferior vena cava
occlusion were used in the derivation of the slope of the
end-systolic pressure-volume relation.
The hemodynamic data for Posicor and epinephrine
administration were analyzed using analysis of variance. A
probability level of less than 0.05 was considered signifi-
cant.
Results
Baseline Impedance Catheter Measurements
The impedance catheter generates a signal that can be
displayed and recorded on standard laboratory recording
equipment. Typical analog tracings obtained during an acute
change in loading conditions induced by inferior vena cava
constriction are shown in Figure 1. Also illustrated is the
signal obtained from the ultrasonic crystals implanted in the
left ventricular wall. Of note, impedance volume signals
and crystal dimensions parallel each other. Similar findings
were noted in all animals during inferior vena cava occlusion
and the administration of cardiotonic drugs. Pressure-vol-
Figure 4. Pressure-volume diagrams obtained before (right) and
after (left) dobutamine administration in a representative experi-
ment. Pressure-volume diagrams are shifted leftward with an in-
creased slope. End-systolic slope before dobutamine administra-
tion is 2.6 mm Hg/ml and after dobutamine is 5.8 mm Hg/ml.
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Figure 5. Pressure-volume diagrams obtained before (right) and
after (left) administration of milrinone in a representative exper-
iment. The diagrams are shifted to the left with an increase in
slope of the end-systolic pressure-volume relation after milrinone.
End-systolic slope before milrinone is 3.3 mm Hg/ml and after
milrinone is 6.6 mm Hg/ml.
ume diagrams and pressure-dimension diagrams obtained
during the inferior vena cava occlusion in Figure 1are shown
in Figure 2. Of note, both the end-systolic pressure-volume
and pressure-dimension relation appear linear.
Figure 3 shows pressure-volume diagrams obtained dur-
ing two sequential inferior vena cava occlusions. The end-
systolic pressure-volume relation appears similar in both
cases. Similar results were found in all animals, suggesting
a high degree of reproducibility of the technique.
Effect of Inferior Vena Cava Occlusion
Inferior vena cava occlusion successfully decreased pre-
load in all animals, resulting in as much as a 60 mm Hg
fall in left ventricular systolic pressure over 10 to 15 sec-
onds. There were no significant heart rate changes during
a decrease in systolic pressure from 15 to 20 mm Hg. With
larger decreases in systolic pressure due to more prolonged
vena cava occlusion, there was a variable increase in heart
rate by as much as 30% (range 0 to 30%).
Part 1. Effects of milrinone and dobutamine. The
administration of dobutamine resulted in a mild increase in
heart rate (90 ± 6 to 98 ± 7 beats/min, p < 0.05), an
increase in cardiac output (2.1 ± 0.6 to 2.4 ± 0.8 li-
ters/min, p < 0.05) and an increase in left ventricular pres-
sure (120 ± 20/8 ± 4 to 148 ± 30110 ± 4 mm Hg, p <
0.01). Milrinone similarly produced an increase in heart
rate (100 ± 10 to 110 ± 7 beats/min, p < 0.05) and car-
diac output (2.2 ± 0.3 to 2.5 ± 0.8 liters/min, p < 0.05),
but resulted in mild fall in left ventricular pressure (115 ±
12/8 ± 4 to 105 ± 10/6 ± 4 mm Hg, p < 0.05). Figures
4 and 5 show representative examples of pressure-volume
loops obtained before and after the administration of dobu-
tamine and milrinone, respectively. Both drugs resulted in
a leftward shift of the end-systolic pressure-volume relation
with an increased slope suggesting an increase in inotropic
state. In dogs that received dobutamine, the slope of the
end-systolic pressure-volume relation increased from 3.0 ±
Table 1. Hemodynamic Data on Posicor and Epinephrine Administration in 14 Pigs
Posicor
Epinephrine
Dose 1 Dose 2 Dose 3 Infusion
Baseline (30 JLg/kg) (100 JLg/kg) (300 JLg/kg) (2 JLg/min)
HR 95 ± 6 101 ± 8 110 ± 10 126 ± 6* 112 ± 9
LVSP 101 ± 8 105 ± 10 98 ± 8 93 ± 7* 125 ± lit
LVEDP 8 ± 4 7 ± 3 7 ± 4 7 ± 2 8 ± 4
RAP 6 ± 2 6 ± 2 6 ± 3 5 ± 3 7 ± 2
PAP 30 ± 12 28 ± 10 29 ± 9 29 ± 8 24 ± 7
PCWP 8 ± 2 7 ± 3 8 ± 5 8 ± 1 9 ± 3
CO 2.0 ± 0.9 2.1 ± 1.1 2.1 ± 1.2 2.4 ± 1.1* 3.5 ± 1.6t
SVR 3,873 ± 314 4,030 ± 386 3,665 ± 424 3,021 ± 444* 3,068 ± 679*
PVR 810 ± 94 780 ± 96 767 ± 104 677 ± 111 399 ± 100
+dP/dt 1,615 ± 116 1,584 ± 131 1,612 ± 164 1,813 ± 145 2,902 ± 123*
Emax. 2.6 ± 0.9 2.4 ± 0.8 2.6 ± 0.9 2.0 ± 0.4 4.9 ± 2.3t
*p < 0.05; tp < 0.01. CO = cardiac output (liters/min); +dP/dt = peak positive dP/dt (mm Hg/s);
HR = heart rate (beats/min); LVEDP = left ventricular end-diastolic pressure (mm Hg); LVSP = left ventricular
systolic pressure (mm Hg); PAP = mean pulmonary artery pressure (mm Hg); PCWP = pulmonary capillary
wedge pressure (mm Hg); PVR = pulmonary vascular resistance (dyne-s-cm r '): RAP = right atrial pressure
(mm Hg); SVR = systemic vascular resistance (dyne-s-cm - 5); Em•x = slope of the end-systolic pressure:
volume line (mm Hg/ml).
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Figure 6. Pressure-volume diagrams obtained before (r ight) and
after (left) administration of epinephrine. End-systolic slope has
increased from 3.3 to 12.1 mm Hg/mJ.
1.4 to 5.6 ± 1.5 mm Hg/ml (p < 0.01). In dogs that re-
ceived milrinone, this slope increased from 3.5 ± 1.0 to
5.9 ± 1.6 mm Hg/ml (p < 0.0 1).
Part 2. Effects of epinephrine and posicor. Table 1
summarizes complete hemodynamic data obtained for the
administration of these drugs. Figures 6 and 7 show pres-
sure-volume loops obtained in pigs before and after the
administration of epinephrine and Posicor, respectively.
Epinephrine resulted in a leftward shift of the end-systolic
pressure-volume relation with an increase in slope as well
200
as in dP/dt and cardiac output. Posicor resulted in no sig-
nificant change in the end-systolic pressure-volume relation
with no change in dP/dt, although there was a mild fall in
systemic vascular resistance with a subsequent increase in
cardiac output. The data suggest little or no significant ino-
tropic change with Posicor but a mild vasodilatory effect.
Discussion
In the present study, we examined the utility of a new
method (measurement of impedancevolume during transient
inferior vena cava occlusion) for determining the relative
inotropic properties of several drugs. This method of de-
termining left ventricular volume has the advantage of al-
lowing for the determination of dynamic pressure-volume
relations during acute alterations in left ventricular loading
conditions. We utilized this property in the determination
of the end-systolic pressure-volume relation of the left ven-
tricle, a known measure of the contractile state of the heart
that is largely independent of loading conditions. Our data
suggest that dobutarnine, milrinone and epinephrine all have
a positive inotropic effect, while Posicor appears to alter
hemodynamics only by acting as a vasodilator.
Potential Utility of the Impedance Catheter for
Measuring End-Systolic Contractile Indexes
Rationale. The theoretic appeal of end-systolic pressure-
volume contractile indexes lies in their load independence
Figure 7. Pressure-volume diagrams obtained before (r ight) and
after (left) administration of Posicor. No significant change was
noted in the end-systolic pressure-volume relation. End-systolic
slope before Posicor is 2.7 mm Hg/ml and after Posicor is 2.8 mm
Hg/ml.
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so that they can presumably be used to assess basal con-
tractility and inotropic modulation . Use of these indexes
could potentially improve our assessment of left ventricular
pump function in a wide variety of pathophysiologic states.
Until recently, however, derivation of these indexes in hu-
mans has been difficult . Angiographic methods are hindered
by the limited number of cardiac cycles that can be analyzed ,
a high incidence of ventricular arrhythmias , the presence of
regional wall motion abnormalities that make geometric as-
sumptions for volume calculations inaccurate, the effect of
iodinated contrast medium on ventricular function, and the
risk to the patient from multiple contrast injections. Simi-
larly, echocardiographic methods are limited by difficulties
of echo visualization in many patients and regional wall
motion abnormalities that adversely affect geometric volume
calculations.
In view of the technical limitations associated with cur-
rent methods of serial volume analysis over a physiologic
range of ventricular loading conditions , there has been
interest in new methods of cardiac chamber volume
measurement in an attempt to facilitate end-systolic pres-
sure-volume analysis . Theoretically , impedance volume
measurement could improve end-systolic pressure-volume
analyses by being able to produce an unlimited number of
beat to beat pressure-volume diagrams over a wide range
of loading conditions. Results from this study and others
(10) in both animals and humans suggest that impedance
measurement s can be used to determine baseline end-sys-
tolic indexes and to assess changes in the end-systolic pres-
sure-volume relation secondary to changes in inotropic state .
The applicability and utility of impedance-catheter deter-
mined volume measurements for ascertaining the end-sys-
tolic pressure-volume relation in humans deserves further
investigation. In this regard, our laboratory is currently
studying the use of a left ventricular impedance catheter in
patients in combination with transient balloon occlusion of
the inferior vena cava to determine end-systolic contractile
indexes .
Application. As addressed by this study, one area in
which impedance end-systolic measurement might be ap-
plicable is the assessment of the mechanism of action of
experimental cardiotonic drugs. The mechanism of action
of some of the newer cardiotonic agents may be difficult to
discern from traditional hemodynamic variables, because
the vasodilating and positive inotropic properties (that es-
sentially all of these agents possess) may produce similar
changes in the measured variables (12). It is only with
careful attention to the preload and afterload status of the
heart that the most reliable isovolumic phase indexes (that
is, peak positive dP/dt, dP/dtp4o , and so on) can be applied.
Because the determination of the slope of the end-systolic
pressure-volume relation incorporates afterload and is in-
dependent of preload (1,2), the validity of this index of
contractility might find wide application in the evaluation
of new cardiac drugs if a simple and reliable method of
determining the pressure-volume relation over a wide range
of arterial pressures were available . The present study sug-
gests that impedance volume measurements are uniquely
suited for this type of analysis and thus may serve as a
suitable technique for drug testing in the future.
Limitations. This study examined only relative volume
changes in a determination of baseline end-systolic pressure
and volume and after inotropic modulation. Once the sur-
gical preparation was completed , impedance catheter po-
sition and sensing characteristics were not altered and the
baseline impedance volume detected through the course of
a single study remained constant. All volume changes sec-
ondary to inferior vena cava occlusion and drug adminis-
tration were measured relative to the initial end-diastolic
impedance volume (VI) and the initial end-systolic imped-
ance volume (VI - forward stroke volume). Thus each
animal served as its own control , and inotropic changes in
the end-systolic pressure-volume relation were assessed rel-
ative to baseline . Utilizing this method, we were able to
determine an absolute end-systolic pressure-volume slope,
termed " Emax" by Suga and Sagawa (I ), but not an absolute
volume intercept of the end-systolic pressure-volume rela-
tion.
Difficulties in determining absolute impedance volumes
had been previously reported (9) , although Baan et al. (10)
were recently successful in measuring accurate absolute
impedance volumes. Perhaps the major problem in the cal-
ibration of impedance volume is the issue of parallel con-
ductance , that is, the leakage of driving current through
nonblood tissues of the myocardium and surrounding struc-
tures . We do not consider this to be a problem in the present
study. The frequency of the alternating current used in the
impedance catheter device is such that the electrical imped-
ance of the myocardium is approximately 100-fold greater
than that of the blood, tending to contain the current and
to render changes in myocardial impedance relatively in-
significant in comparison with changes in blood volume (9).
Additionally , we were able to show a good correlation be-
tween the left ventricular dimension as determined by ul-
trasonic crystals and the impedance catheter-derived ven-
tricular volume.
Additional limitations of this study need to be empha-
sized . Because the impedance catheter is measuring volume
changes from a pair of sensing electrodes located within the
left ventricular cavity, the end-systolic indexes generated in
this study represent regional contractility measurements. It
is possible that these indexes do not represent global con-
tractile performance, particularly in animals with marked
regional contractile variations . This is, of course , a criticism
of the present study and not of the impedance catheter tech-
nique in general, because the sensing electrodes that are
used to measure ventricular volume can be chosen to span
the entire ventricular cavity.
A final limitation of the present study includes the use of
thermodilution cardiac output to determine left ventricular
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stroke volume and thereby calibrate relative volume changes
measured with the impedance catheter. Thermodilution
measurements may vary as much as 10 to 15% and, as a
result, our determination of end-systolic slopes would be
expected to vary in a similar fashion. Much more important
than the determination of an individual slope, however, are
the gross pressure-volume diagram changes that were ob-
served (Fig . 4 through 7). Even without knowledge of cal-
culated individual end-systolic slopes, by visual inspection
it is clear which agents cause positive inotropic changes (for
example, dobutamine, milrinone, epinephrine) and which
produce no change in contractile state (for example, Posi-
cor).
Use of Transient Inferior Vena Cava Occlusion to
Alter Loading Conditions
Any method that attempts to determine end-systolic con-
tractile indexes must by definition include a technique for
altering ventricular preload or afterload , or both , without
changing contractile state. Previous attempts to do this in
the intact animal have primarily involved the use of phar-
macologic agents (for example, nitroprusside, nitroglycerin,
phenylephrine) to change filling pressures and systolic blood
pressure. Sympathetic reflex changes in response to load
alteration , as indicated by changes in heart rate, have been
a consistent problem with this technique. As a result, use
of pharmacologic agents to alter load has also necessitated
the administration of atropine or beta-adrenergic blocking
agents, or both, in the organism to blunt the effect of reflex
contractile changes. The administration of either atropine
or beta-blockers, however, presumably changes baseline
contractility. As an alternative, transient inferior vena cava
occlusion offers a potentially new technique for changing
loading conditions without inducing major sympathetic re-
flexes. As can be seen from Figure I, decreasing an animal's
blood pressure by as much as 50 mm Hg with inferior vena
cava occlusion does result in a mild increase in heart rate,
indicating at least a mild sympathetic discharge. However,
no change in heart rate is noted over a smaller decrease in
blood pressure (for example, 15 to 20 mm Hg) , suggesting
a constancy of contractile state. Further support for the use
of transient inferior vena cava occlusion as a suitable load-
altering technique was recently cited by Bashore et al. (13) ,
who utilized transient vena caval balloon occlusion in 12
patients to acutely decrease preload . Their study showed
that with a mean change of left ventricular systolic pressure
from 120 ± 29 to 104 ± 23 mm Hg, there was no change
in heart rate. Further studies on the use of this technique to
acutely change preload while minimizing cardiovascular re-
flexes are thus indicated.
Posicor: inotrope or vasodilator? We cannot exclude
species differences or the effect of surgical preparation and
anesthesia as the reason for the apparent lack of positive
inotropy of Posicor. Also, the dose at which an increase in
contractility of the myocardium of the pig might occur is
not known. Moreover, our animals did not have an induced
state of cardiac failure and must be considered normal an-
imals from a cardiovascular standpoint. Still another con-
sideration with the acute intravenous administration of Pos-
icor is the potential effect of the diluent on cardiac function .
Although the diluent's hemodynamic effects were transient,
ethanol and polyethylene glycol are known to be negative
inotropic agents and may have counteracted potential pos-
itive inotropic effects of Posicor . In spite of the lack of a
major inotropic effect of Posicor, the drug did produce an
improvement in cardiac output. This can be accounted for
by the decrease in systemic vascular resistance or the in-
crease in heart rate, or both, at similar right and left heart
filling pressures. We conclude from these data that the
mechanism of beneficial effect noted with Posicor is pri-
marily a result of vasodilator rather than positive inotropic
properties .
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